NFKB1 and neoplasm: developed the IKFM transgenic mouse model to assess the impact of increased macrophage NF-κB activity on synthetic mouse models of TBR5 and ID8-Luc OC during two distinct timeframes: 1) established tumors; and 2) during tumor implantation and early tumor growth.